Fact CheckerSign in

NCT05417555Active, not recruiting

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

Modulation of Hippocampal Circuitry and Memory Function With Focused Ultrasound in Amnestic MCI

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

The goal of this study is to investigate whether Low Intensity Focused Ultrasound Pulsation (LIFUP) targeting a part of the brain involved in memory will have an affect on brain activity and whether it may improve memory in people with Mild Cognitive Impairment and Mild Alzheimer's Disease. The main questions the study seeks to answer are: 1. Can LIFUP increase brain activity in the targeted area? 2. Can LIFUP improve memory in people with MCI and mild AD? 3. Can LIFUP improve connectivity of memory networks in the brain? Participants in this study will complete MRIs and memory testing, and receive Low Intensity Focused Ultrasound to a part of their brain involved in memory (the entorhinal cortex).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
120 (actual)
First submitted
1 Jun 2022
Start date
1 Sept 2022
Primary completion date
15 Sept 2026
Lead sponsor
University of California, Los Angeles
NCT number
NCT05417555

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 1 Sept 2022 to the primary completion date, 15 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Active use of immunotherapeutic medications for cognition (Aduhelm, Leqembi, Kisunla)
  • Difficulties during previous MRIs
  • Metal implants that are MR-incompatible, or where participant is unable to provide sufficient information to determine MR compatibility
  • Previous injury by metallic foreign body (e.g., bullet, BB, shrapnel) where the object entered the body and participant lacks doctor's confirmation that it was fully removed
    • Medical:
  • History of 2 or more seizures or diagnosis of epilepsy, unless the seizures occurred prior to age 5 alongside a fever.

Other illness

  • Any of the following implants: Cardiac Pacemaker, Aneurysm clips, Cochlear implants, Defibrillator, Electrodes or wires, Magnetically-activated device, Spinal cord stimulator, Infusion or insulin pumps, Implanted drug infusion device, Deep brain stimulation device
  • Diagnosis of one or more of the following neurological disorders: Parkinson's disease, Lou Gehrig's disease (ALS), Multiple sclerosis, Cerebral Palsy
  • Diagnosis of one or more of the following genetic disorders: Cystic Fibrosis, Sickle Cell Disease
  • Diagnosis of one or more of the following psychiatric disorders: Bipolar, Psychosis
  • Psychiatric illness that has not been controlled for at least two months (if controlled \>2 months, with or without medication, they are not exclusionary)
  • Severe lung, liver, heart, and/or kidney disease/s (e.g., heart failure, liver failure, and etc...)
  • Diagnosis of thyroid disorder or change of thyroid medication dose within the last 3 months
  • Cancer treatment/s with chemotherapy and/or radiation to head and neck, or stage 4 (metastatic) cancer
  • Autoimmune disorder or viral infection such as HIV, COVID 19, or hepatitis C that has caused current problems with cognition/memory
  • History of substance abuse in the past year
  • History of stroke (Transient ischemic attack / mini-stroke not exclusionary if symptoms lasted \<1 week)
  • History of brain tumor, brain aneurysm, brain hemorrhage, or subdural hematoma (transient ischemic attack not exclusionary)
  • Uncontrolled high blood pressure or diabetes
  • Heart attack within the last year

Other

  • GENERAL
  • Participation in another clinical trial
  • Moderate to Severe Alzheimer's
  • Inability to provide informed consent
    • MRI-Related:
  • Weight exceeding 275 pounds
  • Pregnancy, suspicion of pregnancy, or attempting to become pregnant
  • Claustrophobia
  • Top permanent retainer (bottom only is okay), 5 or more non-removable gold-teeth, metal braces, top spacers, and/or palate expanders
  • Non-removable hairpieces, hairpiece extensions, and/or piercings
  • Facial tattoos or permanent makeup
  • Head injury that resulted in loss of consciousness lasting \>30 minutes, cognitive issues lasting \>18 months, and/or brain abnormalities visible in CT or MRI scan

Who the study is looking for

  • Amnestic MCI or Mild Alzheimer's diagnosis
  • Age 50-90
  • English-speaking
  • Ability to provide informed consent
  • Normal or corrected-to-normal hearing and vision

Age in the registry: 50 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UCLA Semel Institute for Neuroscience and Behavior
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.